Adaptimmune Therapeutics plc earnings per share and revenue

ADAP earnings per share for the last quarter are -0.04 USD whereas the estimation was -0.17 USD which accounts for 75.76% surprise. Company revenue for the same period amounts to 231.00 k USD despite the estimated figure of 25.96 M USD. Estimated earnings per share for the next quarter are -0.15 USD, and revenue is expected to reach 9.88 M USD. Also watch annual changes over time to get a bigger picture of ADAP earnings per share and revenue dynamics.